Cargando…

Enhancing exercise tolerance and physical activity in COPD with combined pharmacological and non-pharmacological interventions: PHYSACTO randomised, placebo-controlled study design

INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is associated with exercise limitation and physical inactivity, which are believed to have significant long-term negative health consequences for patients. While a number of COPD treatments and exercise training programmes increase exercise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Troosters, Thierry, Bourbeau, Jean, Maltais, François, Leidy, Nancy, Erzen, Damijan, De Sousa, Dorothy, Korducki, Lawrence, Hamilton, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Respiratory Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838678/ https://www.ncbi.nlm.nih.gov/pubmed/27075841 http://dx.doi.org/10.1136/bmjopen-2015-010106

Ejemplares similares

Behaviour-change intervention in a multicentre, randomised, placebo-controlled COPD study: methodological considerations and implementation
por: Bourbeau, Jean, et al.
Publicado: (2016)

Mechanisms associated with increased physical activity in patients undergoing self-management behaviour modification in the randomised PHYSACTO trial
por: Bourbeau, Jean, et al.
Publicado: (2021)

Behavioural interventions targeting physical activity improve psychocognitive outcomes in COPD
por: Lavoie, Kim L., et al.
Publicado: (2019)

Investigating fractional exhaled nitric oxide (FeNO) in chronic obstructive pulmonary disease (COPD) and asthma–COPD overlap (ACO): a scoping review protocol
por: Mostafavi-Pour-Manshadi, Seyed-Mohammad-Yousof, et al.
Publicado: (2017)

Maintenance of non-pharmacological strategies 6 months after patients with chronic obstructive pulmonary disease (COPD) attend a breathlessness service: a qualitative study
por: Luckett, Tim, et al.
Publicado: (2021)

Preventing adverse cardiac events (PACE) in chronic obstructive pulmonary disease (COPD): study protocol for a double-blind, placebo controlled, randomised controlled trial of bisoprolol in COPD
por: Martin, Allison, et al.
Publicado: (2021)

Optimising treatment for COPD – new strategies for combination therapy
por: Welte, T
Publicado: (2009)

Effects of pharmacological and non-pharmacological interventions on physical activity outcomes in COPD: a systematic review and meta-analysis
por: Megaritis, Dimitrios, et al.
Publicado: (2023)

Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial
por: Lötvall, J, et al.
Publicado: (2012)

Inhaler technique education in elderly patients with asthma or COPD: impact on disease exacerbations—a protocol for a single-blinded randomised controlled trial
por: Maricoto, Tiago, et al.
Publicado: (2019)

Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study
por: Tan, W C, et al.
Publicado: (2014)

SPACE FOR COPD delivered as a maintenance programme on pulmonary rehabilitation discharge: protocol of a randomised controlled trial evaluating the long-term effects on exercise tolerance and mental well-being
por: Alqahtani, Khaled A, et al.
Publicado: (2022)

Cost-effectiveness of integrated COPD care: the RECODE cluster randomised trial
por: Boland, Melinde R S, et al.
Publicado: (2015)

Coronary heart disease and heart failure in asthma, COPD and asthma-COPD overlap
por: Ingebrigtsen, Truls Sylvan, et al.
Publicado: (2020)

Effectiveness of the Assessment of Burden of COPD (ABC) tool on health-related quality of life in patients with COPD: a cluster randomised controlled trial in primary and hospital care
por: Slok, Annerika H M, et al.
Publicado: (2016)

Randomised placebo-controlled study of the effect of paracetamol on asthma severity in adults
por: Ioannides, Sally J, et al.
Publicado: (2014)

Impact of COPD case finding on clinical care: a prospective analysis of the TargetCOPD trial
por: Haroon, Shamil, et al.
Publicado: (2020)

The boundaries of mild chronic obstructive pulmonary disease (COPD): design of the searching clinical COPD onset (SOON) study
por: Labarca, Gonzalo, et al.
Publicado: (2017)

A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD
por: Wilkinson, Tom M A, et al.
Publicado: (2017)

The effects of a multisite aerobic exercise intervention on asthma morbidity in sedentary adults with asthma: the Ex-asthma study randomised controlled trial protocol
por: Bacon, Simon L, et al.
Publicado: (2013)

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
por: Hanania, Nicola A, et al.
Publicado: (2015)

Lung volume reduction eligibility in patients with COPD completing pulmonary rehabilitation: results from the UK National Asthma and COPD Audit Programme
por: Buttery, Sara C, et al.
Publicado: (2020)

Assessing the impact of COVID-19 measures on COPD management and patients: a simulation-based decision support tool for COPD services in the UK
por: Yakutcan, Usame, et al.
Publicado: (2022)

Impact of cardiovascular comorbidities on COPD Assessment Test (CAT) and its responsiveness to pulmonary rehabilitation in patients with moderate to very severe COPD: protocol of the Chance study
por: Smid, Dionne E, et al.
Publicado: (2015)

Pain in patients with COPD: a systematic review and meta-analysis
por: van Dam van Isselt, Eléonore F, et al.
Publicado: (2014)

Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study
por: Terzikhan, Natalie, et al.
Publicado: (2016)

Complications and discomfort after research bronchoscopy in the MicroCOPD study
por: Leiten, Elise Orvedal, et al.
Publicado: (2020)

Relationship between heart failure and the risk of acute exacerbation of COPD
por: Axson, Eleanor L, et al.
Publicado: (2021)

Effect of acetazolamide on obstructive sleep apnoea in highlanders: protocol for a randomised, placebo-controlled, double-blinded crossover trial
por: Tan, Lu, et al.
Publicado: (2022)

Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations
por: O'Reilly, Philip J, et al.
Publicado: (2013)

Inspiratory crackles—early and late—revisited: identifying COPD by crackle characteristics
por: Melbye, Hasse, et al.
Publicado: (2021)

A randomised controlled trial on the efficacy of advance care planning on the quality of end-of-life care and communication in patients with COPD: the research protocol
por: Houben, Carmen H M, et al.
Publicado: (2014)

β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol
por: Bhatt, Surya P, et al.
Publicado: (2016)

Vitamin D in the prevention of exacerbations of asthma in preschoolers (DIVA): protocol for a multicentre randomised placebo-controlled triple-blind trial
por: Jensen, Megan E, et al.
Publicado: (2019)

Inhibition of bradykinin in SARS-CoV-2 infection: a randomised, double-blind trial of icatibant compared with placebo (ICASARS)
por: Bailey, Melanie, et al.
Publicado: (2023)

Prioritising outcomes for evaluating eosinophil-guided corticosteroid therapy among patients with acute COPD exacerbations requiring hospitalisation: a Delphi consensus study
por: Suehs, Carey Meredith, et al.
Publicado: (2020)

Loss of GD1-positive Lactobacillus correlates with inflammation in human lungs with COPD
por: Sze, Marc A, et al.
Publicado: (2015)

Diagnostic accuracy of screening tests for COPD: a systematic review and meta-analysis
por: Haroon, Shamil, et al.
Publicado: (2015)

Spirometric Values of Greek People and Comparison with ECSC and GLI Values in COPD People
por: Tatsis, Nikolaos, et al.
Publicado: (2018)

Benefits of the ‘village’: a qualitative exploration of the patient experience of COPD in rural Australia
por: Glenister, Kristen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q8ojrfog4d4nvkgjhfb5au5k9c